Siren Biotechnology is a pioneering company in the field of synthetic biology, focusing on developing innovative therapies that harness the power of engineered cells to combat diseases. They generate revenue through the development and commercialization of their proprietary cell-based therapies, often partnering with pharmaceutical companies for distribution and further research. Founded by a team of leading scientists, Siren Biotechnology has made significant strides in the biotech industry, including securing substantial funding and achieving key milestones in clinical trials.